Tag: Cardiovascular Medicine

  • West-Norwegian peripartum cardiomyopathy cases showed recovery

    What the study found

    Peripartum cardiomyopathy, a form of heart failure that occurs at the end of pregnancy or soon after delivery, was uncommon in this West-Norwegian population. The study also found that the patients generally recovered heart function over time.

    Why the authors say this matters

    The authors conclude that higher pre-pregnancy body mass index and elevated systolic blood pressure are important modifiable cardiovascular risk factors associated with peripartum cardiomyopathy. They also say larger collaborative studies are needed to give a reliable nationwide picture of incidence and outcomes.

    What the researchers tested

    This single-center case-control study identified 15 cases of peripartum cardiomyopathy at Haukeland University Hospital from 2011 to 2023. The Bergen Birth Registry was used to estimate total births and recruit 30 age-matched healthy controls, and the researchers collected clinical characteristics, echocardiographic data, and outcomes.

    What worked and what didn't

    The incidence rate was 1 in 4,182 births. Higher pre-pregnancy body mass index and elevated systolic blood pressure were reported as predictors, and pre-eclampsia and primiparity were significantly more common in patients than in controls. Left ventricular ejection fraction increased from 35% at presentation to 58% at 6-month follow-up, and there were no maternal or neonatal deaths; three patients needed intensive care, and none had major cardiovascular events.

    What to keep in mind

    The study was single-center and included only 15 cases, so the sample was small. The abstract also says that future large collaborative studies are necessary to describe incidence and outcomes nationwide.

    • Peripartum cardiomyopathy was identified in 15 cases over 2011 to 2023.
    • The incidence rate was 1 in 4,182 births in this West-Norwegian population.
    • Higher pre-pregnancy body mass index and higher systolic blood pressure were reported as predictors.
    • Pre-eclampsia and primiparity were more common in patients than in controls.
    • Mean left ventricular ejection fraction rose from 35% to 58% by 6 months.
    • There were no maternal or neonatal deaths, and no major cardiovascular events.
  • Ugandan women with PPCM had high 6-month mortality

    What the study found

    The study found substantial illness severity among Ugandan women with peripartum cardiomyopathy, a heart muscle condition that occurs around pregnancy. Over 6 months, 7.5% of the women died, and 46.3% showed left ventricular recovery, meaning the heart's pumping function improved to an ejection fraction of at least 50%.

    Why the authors say this matters

    The authors conclude that the mortality rate was high and aligned with global studies. They also suggest that the observed intracardiac thrombus, which is a clot inside the heart, and stroke burden may indicate severe left ventricular systolic dysfunction at presentation.

    What the researchers tested

    The researchers conducted a prospective cohort study of 80 women with peripartum cardiomyopathy in Uganda and followed them for 6 months while they received goal-directed medical therapy. They performed physical examinations, 12-lead electrocardiography, echocardiography, and biomarker testing, including NT-pro BNP and prolactin, at baseline and follow-up, and recruited 80 matched controls for biomarker comparison at baseline.

    What worked and what didn't

    Among the women with peripartum cardiomyopathy, the mean left ventricular ejection fraction was 35.7% and 27.5% had an ejection fraction below 35%. Severe right ventricular systolic dysfunction was seen in 7.5%, 25% were in New York Heart Association class IV, 10% had intracardiac thrombus, and 2.5% developed atrial fibrillation; 65% were in New York Heart Association class I by 6 months, and 46.3% had left ventricular recovery. Fifty-four participants received bromocriptine in addition to other therapy, but the abstract does not separate its effect from the rest of the treatment.

    What to keep in mind

    The abstract does not describe the study's limitations in detail. It also does not show whether the recovery seen after 6 months was caused by bromocriptine, other medical therapy, or the natural course of the condition.

    • The study followed 80 Ugandan women with peripartum cardiomyopathy for 6 months.
    • Seven-point-five percent of the women died during follow-up.
    • Forty-six point three percent had left ventricular recovery by 6 months.
    • Intracardiac thrombus was documented in 10% of participants, and atrial fibrillation in 2.5%.
    • Most participants (68%) received bromocriptine in addition to goal-directed medical therapy.